Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:

Boston Scientific Puts Its Own Stamp On New Line Of Pacemakers

This article was originally published in The Gray Sheet

  • News

Executive Summary

Boston Scientific is launching its first in-house line of pacemakers since entering the cardiac rhythm management market with its 2006 purchase of Guidant

You may also be interested in...



Boston Scientific Predicts 2009 Will Be The Year Guidant Buy Proves Wise

Boston Scientific CEO Jim Tobin says 2009 will be the year when his company's gamble on cardiac rhythm management begins to pay off the way it hoped when it entered the CRM business by buying Guidant in 2006

Boston Scientific Predicts 2009 Will Be The Year Guidant Buy Proves Wise

Boston Scientific CEO Jim Tobin says 2009 will be the year when his company's gamble on cardiac rhythm management begins to pay off the way it hoped when it entered the CRM business by buying Guidant in 2006

Boston Scientific: Tobin Broadens Horizons, LaViolette To Leave

Boston Scientific CEO Jim Tobin will begin managing day-to-day operations across the company now that the firm's cardiac rhythm management business is stabilized, the firm said June 3

Table

View full table

Related Content

Medtech Insight
Tags:
Latest Headlines

‘Core Pillars’ Of Safety And Innovation Take Center Stage In FDA Reports

Behavioral Health Company Two Chairs Secures $72M In Equity And Debt Infusion

Clinical Trial Diversity Requires Sponsors Work With An Assortment Of Patient Advocates, Community Organizations

Israeli Company Lands De Novo Clearance For Digital Bone Marrow Application

See All
UsernamePublicRestriction

Register

MT026093

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By